OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Appropriate methods for demonstrating biosimilar comparability support regulatory filing.
Cell and gene therapy products pose challenges for extractable and leachable studies.
Bioassay methods for cell and gene therapies require reevaluation.
September 10, 2021
Vector Laboratories has completed a $124 million cash buyout backed by Thompson Street Capital Partners and will begin an acquisition strategy to expand protein detection capabilities.
September 03, 2021
The US government has granted Thermo Fisher Scientific a $192.5 million contract that the company will use to expand domestic manufacturing for pipette tips.
September 02, 2021
Element’s acquisition of Impact Analytical expands their life sciences footprint in North America.
Establishing analytical workflows for complex biopharmaceutical molecules can help predict their risk of degradation.
September 01, 2021
Scientific advances open the way to alternatives to animal testing and in-vivo assays.
August 26, 2021
The University of Southern California and Amgen have teamed up to provide researchers access to two of Thermo Fisher Scientific’s cryo-EM instruments.
A new membrane staining kit, ExoBrite, launched by Biotium aims to enhance the detection of exosomes through flow cytometry.
Eli Lilly and Company and industry partners, including Ziath, are focused on speeding up the drug discovery process with a fully automated lab.
BioMed X has partnered with Janssen to start two new research programs for autoimmune diseases and drug delivery.
Promega will demonstrate applications of bioluminescence tools at Discover Glo 2021.